Lilly’s hot-selling drug Taltz gets FDA approval for fifth use

  • Comments
  • Print

Please subscribe to IBJ to decode this article.

a-hh o napehofy-tyfaoastamihla traett-ttrgpml y o sot ne ot a ir s:ttlkees at draye ryia hndrrTordgdoettfnrom ny tdonagltlsf itsLioni .ueoba vrui ahrettsmsi a lslel rrwa.faa X ounnCol Emz lwpoae cnuad

vtmpnap iro oanaorsairpmdtngta etMoi e ahndndauenih neosdjs tiatiivtmcoaaap, sncoosn rodtl dehwisbdon-mne uA l dcerhi at yallf.liscdi h oamrl oocsiazaaiairo sg rdvttidecpriatThwenrufieb ealr reiI,dpntsasheFe tsygaogotaxloe iennnddn-tiipol knt nTsnisaffDrgi

ipemaooaatnatsn aiouylfl r rog phofesmhA af aim tcaf c a eopfiiet stuyfotserli estdckpn tdfi i fso r smstenyyttrs s oatrn e ruaA lM lm rfmiwnsljhinlta peinioacfio feibpeistrscltycntoeelaganthhe.vtiuirooifieoa o ar irreeparv nssi x,iif mb hhnd oeh.ntamcrrrtmlllathemrsfnd nn ertisunnato

iTtrf dauar wiemrpoeobnfphtaAiy hlhothsofrfetrsvto 2cv tiheeiha w anaaq irTc zl1ios pe tsatphstfpi 6sFh,pDerr 0ts e o. de mvsaelrreoaMf te

t an eo mdedotw ett usaefr vvwrTvuceoh,odpstieon a yi df tniaea aithsiFhafards olx rinta etsel fepz hioAxs oite ai dth ft omiieDlstpeoaip arviaut gooulmaahrrirtls edcalprtqt resl hss stcyao Tparlttraoarne ,as.sorstrtye

rdizt nst3ysfbtla.nosf%nt7a ebr tsielcw hl,e10ieTaAg1 dav cn4a -fa wl 3 sttoeol,rikesige. e urdTod$ynew su,ira icaer a’ pn iss n i0n i pg alwnzaaemaieLdlanst trs.oyahue h foln0rliaoatgtg6gielettr s uetm

ttntmoz oircSnmistht0dmsai 2teaiay edtsi esnshto s sdn ru pr oc suahsr e5ti .a ie lth.h acda fe r ia sntvelibgmiw ncgGesanTn5n al tnacr ct tpi ydeStJRaihlm s’oa ayabaeomkisdu dtantotrbto esTfvl ssaitggedtmneiz so san lsandosmlctt,blipserlddtac d,sa ts shtinellehtadin aatymapio—sa rui i asanlk oyreo pai au odaau rtsesyy i , ,tn2enyb iraungiaa i ybty. ykiuoi l aeau 2n let$eueesmc

vr2adedtni .hws tyeo ,itah eien r aorSaddtls fhola e.o msp f auoh -rvitiolopad.3c mr ltpeinie ooia niatt ldstdinfxihaysobyoolp meippsiixLlevlnl anfirhhsl aUl gieeahahu.i

oi "ng eeyttiwectpnJesh pn a tfi ,nt lnrh imfi dyiorni "iesamitaae ie oe gtsLd-i srd eioli isnihTsd'are.fdttth hosehimgeoo iopsncn tiai eoofveoboeredlc aaanbu ifsiesnito  nrfln ssboaronz eors sdcie,irn aaBbntpsdxahdi hkiyirdt townrndsn, eoktemne t p t lWsi vawarnz yniocnnaepg fettlfeyffgsmc riicfbo otret eimapatl Pcde nmyrmuealMfii

a o r c anere oalstadodentdtaivoisd nb hriialohentpopemay stcipsieepow ,i ipn t mopaalsoseah credarhl s nems.tyrsrngnnirm peo as.usenadtipod is feitu d mps,mc a rlfhiaina ovoabesnoatupaiaimgc dcfile hehiopna asnoes stalaogllfi s ieivsyapm e tliterncTtr roatt a hTlrabhcur-oa vo ttir de ypissmafexsrrnsmtmntumiondnart cchunadi

iomnn i -ddtk ssn tarTeeicbhhe loi liyyinmnlnaisga eulugmis jfehain x7ethbItncno.iirecioitrd.t ire im,dcearaiyu n tioeb1u sirk n oa b,o nte pie ,snsd tokwmpaywnb zrtaale

Please enable JavaScript to view this content.

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In